IDEXX Laboratories, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abaxis and others are Dominating the Market for U.S. Veterinary Diagnostics Market in 2017

U.S. Veterinary Diagnostics Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Access Full Report:

The U.S. veterinary diagnostics market highly concentrated to a few big players and rest to local players who cater to domestic markets only. IDEXX Laboratories, Inc. dominated the veterinary diagnostic market accounting for a highest market share in 2017, followed by QIAGEN, Thermo Fisher Scientific Inc., Abaxis. Other players in this market include are bioMérieux SA,Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems, Inc. ,Heska ,NEOGEN CORPORATION, Randox, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Zoetis among others.

IDEXX Laboratories, Inc.:

IDEXX Laboratories, Inc. founded in 1987 and headquarters in Maine, U.S., focuses on in enhancing the health and well-being of pets, people and livestock. It operates its business through CAG, water, LPD and other. It offers veterinary diagnostic products through its CAG (Companion Animal Group).

The company has it presence in U.S., The Netherlands, and China.

  • In December 2009, IDEXX Laboratories, Inc. acquired Optic Medical Systems (U.S.). This acquisition expanded IDEXX Laboratories, Inc. Opportunities for future growth and development of strong, diverse portfolio of veterinary diagnostics.


QIAGEN founded in 1980 and based in U.S. It is focuses on delivers sample to insight solutions for molecular testing. It operates its business through acute consumable and related, instrumentation. It offers veterinary diagnostic products through its instrumentation. The company has its presence in America, Europe, Middle East and Africa, Asia Pacific and Rest of World.

  • In January, QIAGEN N.V. (U.S.) acquisition of STAT-Dx Life S.L.(Spain) for PCR-based multiplex syndromic testing solution. This acquisition helpful in advancement PCR.

Thermo Fisher Scientific Inc.:

Thermo Fisher Scientific Inc. founded in 1956 and headquarters in U.S., focuses Company manufactures analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. It operates its business in North America, Europe, Asia-Pacific, and Rest of World.

  • In 2018 June, Thermo Fisher Scientific Inc. (U.S.) discover 3.0 software in molecule analysis. The software provided the information data generated from high-resolution accurate-mass (HRAM) Orbitrap mass spectrometers and transforms into significant result.